Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 2/20 | 0.58 |
| ▸ | CA1 | P00915 | 2/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA3 | P07451 | 1/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
| ▸ | CA6 | P23280 | 1/20 | 0.52 |
| ▸ | CA5A | P35218 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11388569 | 0.80 | NAPRT (0.57) | CA1CA2ALDH1A1HSD17B10TDP1 | |
| SCHEMBL2820495 | 0.80 | ALDH1A1 (0.58) | CA1CA2ALDH1A1CA12CA3 | |
| SCHEMBL23845470 | 0.77 | ALDH1A1 (0.54) | ALDH1A1HSD17B10TDP1SMN1; SMN2CYP2C9 | |
| SCHEMBL486841 | 0.77 | HTR6 (0.52) | HTR6CA1CA2ALDH1A1HSD17B10 | |
| Benzenesulfonamide SCHEMBL13452509 | 0.77 | SMN1; SMN2 (0.62) | HTR6CA1CA2ALDH1A1HSD17B10 | |
| SCHEMBL31460982 | 0.77 | HTR6 (0.52) | HTR6CA1CA2ALDH1A1HSD17B10 | |
| SCHEMBL486787 | 0.77 | HTR6 (0.52) | HTR6CA1CA2ALDH1A1HSD17B10 | |
| SCHEMBL25408013 | 0.77 | HTR6 (0.52) | HTR6CA1CA2ALDH1A1HSD17B10 | |
| SCHEMBL486856 | 0.77 | HTR6 (0.52) | HTR6CA1CA2ALDH1A1HSD17B10 | |
| SCHEMBL8580527 | 0.77 | CA1 (0.62) | HTR6CA1CA2ALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116813618-A | Amino-substituted imidazopyridine compound and synthesis method thereof | 郑州泰基鸿诺医药股份有限公司 | 2023-09-29 | — | — | CN | claimed |
| US-12503446-B2 | Bromodomain inhibitors | Forschungszentrum Jülich GmbH (DE) | 2025-12-23 | — | — | US | disclosed |
| US-20250179012-A1 | SYNTHESIS OF SULFUR(VI) COMPOUNDS AND REAGENTS FOR SAME | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. | 2025-06-05 | — | — | US | disclosed |
| WO-2025073057-A1 | METHODS FOR PREPARING SULFILIMINES AND SULFOXIMINES FROM THIOETHERS USING O-(DIPHENYLPHOSPHINYL)HYDROXYL AMINE (DPPH), AND AMATOXIN ANALOGS PREPARED FROM SUCH METHODS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2025-04-10 | — | — | WO | disclosed |
| CN-118420501-A | N-sulfinyl benzoyl hydrazone series compounds and preparation method thereof | 浙大城市学院 | 2024-08-02 | — | — | CN | disclosed |
| CN-116813618-A | Amino-substituted imidazopyridine compound and synthesis method thereof | 郑州泰基鸿诺医药股份有限公司 | 2023-09-29 | — | — | CN | disclosed |
| WO-2023168108-A2 | SYNTHESIS OF SULFUR(VI) COMPOUNDS AND REAGENTS FOR SAME | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) | 2023-09-07 | — | — | WO | disclosed |
| CN-116239547-A | Synthesis method of benzo [ i ] [1,2] thiazine-3, 7, 8-trione-1-oxygen series compound | 浙大城市学院 | 2023-06-09 | — | — | CN | disclosed |
| CN-114133367-B | Preparation method of sulfoxide imido dihydropyrone derivative | 大连理工常熟研究院有限公司 | 2023-03-21 | — | — | CN | disclosed |
| WO-2022261427-A1 | (4-(6-((2-OCTAHYDROCYCLOPENTA[C]PYRROL-5-YL)AMINO)PYRIDAZIN-3-YL)PHENYL)(IMINO)(METHYL)-LAMBDA6- SULFANONE DERIVATIVES AND SIMILAR COMPOUNDS AS MUSCARINIC ACETYLCHOLINE RECEPTOR M4 ANTAGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | VANDERBILT UNIVERSITY (US) | 2022-12-15 | — | — | WO | disclosed |
| WO-1991010648-A1 | DIPHENYLSULPHOXIMINE MUSCARINIC RECEPTOR ANTAGONISTS | PFIZER LIMITED (GB) | 1991-07-25 | — | — | WO | disclosed |
| US-4525586-A | Composition and process | THE UPJOHN COMPANY (US) | 1985-06-25 | — | — | US | disclosed |
| EP-0035969-B1 | COMPOSITION OF CATIONICALLY POLYMERISABLE MATERIAL AND A CATALYST | CIBA-GEIGY AG (CH) | 1985-02-13 | — | — | EP | disclosed |
| US-4420632-A | PROSTAGLANDINS; ANTICOAGULANTS | THE UPJOHN COMPANY (US) | 1983-12-13 | — | — | US | disclosed |
| US-4349689-A | Methano carbacyclin analogs | THE UPJOHN COMPANY (US) | 1982-09-14 | — | — | US | disclosed |
| US-4339567-A | Photopolymerization by means of sulphoxonium salts | CIBA-GEIGY CORPORATION (US) | 1982-07-13 | — | — | US | disclosed |
| US-4306075-A | Composition and process | THE UPJOHN COMPANY (US) | 1981-12-15 | — | — | US | disclosed |
| US-4306076-A | Inter-phenylene CBA compounds | THE UPJOHN COMPANY (US) | 1981-12-15 | — | — | US | disclosed |
| EP-0035969-A1 | Composition of cationically polymerisable material and a catalyst | CIBA-GEIGY AG (CH) | 1981-09-16 | — | — | EP | disclosed |
| US-4105795-A | Antispasmodic substituted sulphoximides | LUDWIG HEUMANN & CO. GMBH. (DE) | 1978-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250179012-A1 | SYNTHESIS OF SULFUR(VI) COMPOUNDS AND REAGENTS FOR SAME | TST, CBS, SQOR | HTR6 2354/4885CA1 1942/4885CA2 2123/4885 |
| US-12503446-B2 | Bromodomain inhibitors | BRDT, BRD4, BRPF3 | HTR6 3390/4885CA1 4251/4885CA2 4236/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.